Epitalon vs GLOW: What Is the Difference?
The smallest molecule in the library against a multi-ingredient mixture. One variable versus several.
In plain English
Epitalon is just four amino acids — the smallest molecule here — distilled from a pineal gland extract studied in the Soviet Union from the 1970s.
GLOW is a 70 mg vial containing GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg, studied together as one preparation.
The difference, without the jargon
This pairing is really about experimental design. Epitalon is a single, very simple molecule: if something happens in your model, there is one candidate for what caused it. A blend deliberately gives up that clarity to cover several biological pathways at once, which is the right tool if your question is about a combination rather than a mechanism. Their research areas differ too — ageing and cellular research for Epitalon, skin structure for the blend. Handling favours Epitalon strongly. At four amino acids with none of the light- or air-sensitive ones, it dissolves instantly and asks very little. A blend inherits the storage requirements of whichever ingredient is fussiest, and keeps only as long as its least stable component.
Common questions
What is the difference between Epitalon and GLOW?
Epitalon is a single four-amino-acid molecule studied in ageing research. GLOW is a 70 mg blend of GHK-Cu, BPC-157 and TB-500. One gives you a single variable; the other covers three pathways at once.
Why is Epitalon so easy to work with?
It is the smallest molecule in the library and contains none of the amino acids that react with light or air. It dissolves instantly and needs little beyond refrigeration and a sound seal.
When would a blend be the better choice?
When the research question is about a combined preparation rather than a specific mechanism. If you need to attribute a result to one molecular event, a single ingredient is the only way to do that cleanly.
Technical reference below
How they actually differ
Comparing the two: Epitalon is synthetic tetrapeptide (ala-glu-asp-gly), while GLOW is three-component dermal research blend — ghk-cu 50 mg / bpc-157 10 mg / tb-500 10 mg (70 mg total) — different molecular classes with different handling consequences; they call for different primary diluents (sterile or bacteriostatic water versus bacteriostatic water (0.9% benzyl alcohol)); their leading degradation routes differ (aspartate-glycine isomerisation for Epitalon, copper dissociation from the ghk-cu component at acidic ph or on contact with chelators such as edta for GLOW), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
Epitalon — origin
Epitalon is a four-residue peptide derived by Vladimir Khavinson's group from Epithalamin, a pineal gland extract studied in the Soviet Union from the 1970s. It represents the reductionist end of the peptide field — the attempt to identify the shortest sequence retaining the activity of a complex tissue extract. At 390 Da it is the smallest compound in this catalogue by a wide margin.
GLOW — origin
GLOW combines three of the most-studied compounds in tissue and dermal research into one 70 mg vial: GHK-Cu (50 mg), BPC-157 (10 mg) and TB-500 (10 mg). The rationale is mechanistic complementarity — GHK-Cu research centres on collagen and extracellular matrix synthesis, BPC-157 on angiogenesis and growth-factor signalling, and TB-500 on actin-mediated cell migration. Three non-overlapping routes into the same repair biology.
Epitalon research themes
The most-cited claim in the Epitalon literature, examined in cell-culture models.
Follows from its Epithalamin origin; studied for effects on circadian signalling in animal models.
A long-running Russian research programme examined lifespan endpoints in rodent models.
Epitalon is the flagship of Khavinson's "peptide bioregulator" framework, a distinct research tradition worth understanding as context.
GLOW research themes
The majority component, with the deepest dermal literature — collagen and glycosaminoglycan synthesis in fibroblast models.
Studied around vessel formation and growth-factor pathways in tissue-repair models.
Actin sequestration and directed cell movement — how cells reach a tissue defect.
The three components act through genuinely non-overlapping mechanisms, which is the rationale for combining them.
Epitalon handling
- Do not over-engineer storage for this compound — refrigeration and a sound seal are genuinely sufficient.
- Avoid prolonged storage of reconstituted solution, since Asp-Gly isomerisation is slow but cumulative.
- Verify the analytical method behind any purity figure, as short polar peptides are easy to under-resolve.
GLOW handling
- Never reconstitute in acidic diluent — this dissociates copper from the GHK-Cu component, which is the majority of the vial.
- Keep chelating agents such as EDTA out of any buffer used with GLOW; they will strip the copper.
- Treat colour as data: clear, even blue is correct. Pale, colourless or green means the GHK-Cu component has degraded.
- Protect from light for the TB-500 and GHK-Cu components, and minimise headspace exposure.
- Do not subdivide the dry cake — three co-lyophilized components do not partition evenly in powder form.
Both third-party tested
Every Popular Peptides batch of Epitalon and GLOW is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
Epitalon reference
Related comparisons
Epitalon and GLOW are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.